School of Medicine


Showing 11-20 of 125 Results

  • Paul Cheng MD PhD

    Paul Cheng MD PhD

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford. His current clinical focus is in amyloidosis and cardio-oncology. During his post doctoral research in the Quertermous lab, he pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome.

    The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.

    Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu

  • Daniel Clark, MD, MPH

    Daniel Clark, MD, MPH

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine
    Clinical Assistant Professor, Pediatrics - Cardiology

    BioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.

    Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.

    Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.

    Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association.

  • William Clusin, MD

    William Clusin, MD

    Associate Professor of Medicine (Cardiovascular Medicine), Emeritus

    Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.

  • John P. Cooke, MD, PhD

    John P. Cooke, MD, PhD

    Professor of Medicine (Cardiovascular Medicine), Emeritus

    Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).

  • Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick

    Rajesh Dash, MD PhD; Director of SSATHI & CardioClick

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsI have two research areas:
    1) Heart disease in South Asians - genetic, metabolic, & behavioral underpinnings of an aggressive phenotype.

    2) Imaging cell injury & recovery in the heart. Using Cardiac MRI to visualize signals of early injury and facilitating preventive medical therapy. Optimizing new imaging methods for viable cells to delineate live heart cells or transplanted stem cells.

  • Rajiv Doshi, MD

    Rajiv Doshi, MD

    Adjunct Professor and Director, India Biodesign Program, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsDr. Rajiv Doshi serves as an Adjunct Professor of Medicine and as the Director of the India Program at the Byers Center for Biodesign. Dr. Doshi is also the co-Director of the India-based Founders Forum, an executive education training program for India’s leading health technology entrepreneurs. He has also advised the Government of India and various Indian state governments in the development of policies that support Indian health technology innovation.

  • Zachary Edmonds, MD, MBA

    Zachary Edmonds, MD, MBA

    Academic Staff - Hourly - CSL, Medicine - Cardiovascular Medicine
    Adjunct Professor, Medicine - Cardiovascular Medicine

    BioAdjunct Professor of Medicine | Cardiovascular Medicine | Stanford Medicine

    Seasoned clinician with a proven track record of mentoring medtech entrepreneurs and early stage companies in the development of life changing technologies. As the Associate Director of the PAMF Hospital Medicine service line he co-leads a team of 30 physicians across 3 community hospitals in the Bay Area. When not seeing patients, he serves as the Chief Medical Officer at Fogarty Innovation where he mentors a variety of early stage companies. As an Adjunct Professor of Medicine at Stanford he works closely with the Biodesign group to teach and mentor students and Biodesign fellows. He co-teaches the Biodesign Innovation graduate course which is offered to Stanford graduate students in the school of medicine, school of engineering and the graduate school of business each winter and spring quarter. Zach holds an MD from the UCLA School of Medicine and an MBA from the UCLA Anderson School of Management. He completed Internal Medicine Residency and the Biodesign Fellowship at Stanford University.